Published in PLoS One on April 09, 2013
The vaginal microbiota: what have we learned after a decade of molecular characterization? PLoS One (2014) 1.43
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol (2015) 1.07
Functional genomics of lactic acid bacteria: from food to health. Microb Cell Fact (2014) 1.06
Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis. PLoS One (2013) 0.93
Vaginal microbiome in women from Greenland assessed by microscopy and quantitative PCR. BMC Infect Dis (2013) 0.91
The significance of Lactobacillus crispatus and L. vaginalis for vaginal health and the negative effect of recent sex: a cross-sectional descriptive study across groups of African women. BMC Infect Dis (2015) 0.89
Comparative genomics of Lactobacillus crispatus suggests novel mechanisms for the competitive exclusion of Gardnerella vaginalis. BMC Genomics (2014) 0.86
Dysbiosis of upper respiratory tract microbiota in elderly pneumonia patients. ISME J (2015) 0.85
Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. Eur J Clin Microbiol Infect Dis (2015) 0.84
The potential of metatranscriptomics for identifying screening targets for bacterial vaginosis. PLoS One (2013) 0.82
Clinical and microbiological characteristics of Eggerthella lenta bacteremia. J Clin Microbiol (2014) 0.81
Cervical microbiota in women with preterm prelabor rupture of membranes. PLoS One (2015) 0.81
Anaerobes and bacterial vaginosis in pregnancy: virulence factors contributing to vaginal colonisation. Int J Environ Res Public Health (2014) 0.80
Evaluation of Lysis Methods for the Extraction of Bacterial DNA for Analysis of the Vaginal Microbiota. PLoS One (2016) 0.79
Pathogenic bacterial species associated with endodontic infection evade innate immune control by disabling neutrophils. Infect Immun (2014) 0.79
Longitudinal analysis reveals characteristically high proportions of bacterial vaginosis-associated bacteria and temporal variability of vaginal microbiota in northern pig-tailed macaques (Macaca leonina). Dongwuxue Yanjiu (2015) 0.79
Sensitive Detection of Thirteen Bacterial Vaginosis-Associated Agents Using Multiplex Polymerase Chain Reaction. Biomed Res Int (2015) 0.78
Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis. Antimicrob Agents Chemother (2015) 0.78
Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin. Anaerobe (2017) 0.77
Cervical Microbiome and Cytokine Profile at Various Stages of Cervical Cancer: A Pilot Study. PLoS One (2016) 0.77
Taxonogenomics and description of Vaginella massiliensis gen. nov., sp. nov., strain Marseille P2517(T), a new bacterial genus isolated from the human vagina. New Microbes New Infect (2016) 0.75
Screening of Compounds against Gardnerella vaginalis Biofilms. PLoS One (2016) 0.75
Mechanistic Insights Underlying Tolerance to Acetic Acid Stress in Vaginal Candida glabrata Clinical Isolates. Front Microbiol (2017) 0.75
The influence of sexual activity on the vaginal microbiota and Gardnerella vaginalis clade diversity in young women. PLoS One (2017) 0.75
Bacterial vaginosis diagnosed by analysis of first-void-urine specimens. J Clin Microbiol (2013) 0.75
Comparative Study on the Vaginal Flora and Incidence of Asymptomatic Vaginosis among Healthy Women and in Women with Infertility Problems of Reproductive Age. J Clin Diagn Res (2017) 0.75
Comparative analysis of vaginal microbiota sampling using 16S rRNA gene analysis. PLoS One (2017) 0.75
Clinical Validation of a Test for the Diagnosis of Vaginitis. Obstet Gynecol (2017) 0.75
Bacterial communities found in placental tissues are associated with severe chorioamnionitis and adverse birth outcomes. PLoS One (2017) 0.75
Supplemental thymol and carvacrol increases ileum Lactobacillus population and reduces effect of necrotic enteritis caused by Clostridium perfringes in chickens. Sci Rep (2017) 0.75
Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol (1991) 20.49
Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med (1983) 16.63
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A (2010) 12.39
Molecular identification of bacteria associated with bacterial vaginosis. N Engl J Med (2005) 11.23
The RDP (Ribosomal Database Project) continues. Nucleic Acids Res (2000) 10.03
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med (1988) 5.32
Cloning of 16S rRNA genes amplified from normal and disturbed vaginal microflora suggests a strong association between Atopobium vaginae, Gardnerella vaginalis and bacterial vaginosis. BMC Microbiol (2004) 4.60
Differences in the composition of vaginal microbial communities found in healthy Caucasian and black women. ISME J (2007) 4.36
Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis (2008) 3.90
Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. Clin Infect Dis (2003) 3.24
Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. Clin Infect Dis (2003) 3.20
Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis (1991) 3.17
Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol (2007) 3.10
Bacterial communities in women with bacterial vaginosis: high resolution phylogenetic analyses reveal relationships of microbiota to clinical criteria. PLoS One (2012) 2.79
Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis. Appl Environ Microbiol (2008) 2.73
Vaginal lactobacillus flora of healthy Swedish women. J Clin Microbiol (2002) 2.67
Deep sequencing of the vaginal microbiota of women with HIV. PLoS One (2010) 2.59
Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. Lancet Infect Dis (2005) 2.42
The vaginal microbiome: new information about genital tract flora using molecular based techniques. BJOG (2011) 2.41
Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR. J Clin Microbiol (2009) 2.29
Validation of a simplified grading of Gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect (2002) 2.25
Genetic diversity of vaginal lactobacilli from women in different countries based on 16S rRNA gene sequences. J Appl Microbiol (2002) 2.22
Cultivation-independent analysis of changes in bacterial vaginosis flora following metronidazole treatment. J Clin Microbiol (2007) 2.06
Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC Genomics (2010) 2.04
Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. J Infect Dis (2008) 1.99
Bacterial vaginosis: a public health review. BJOG (2001) 1.95
Lower genital tract infection and endometritis: insight into subclinical pelvic inflammatory disease. Obstet Gynecol (2002) 1.85
Culture-independent analysis of vaginal microflora: the unrecognized association of Atopobium vaginae with bacterial vaginosis. Am J Obstet Gynecol (2004) 1.83
Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol (1996) 1.72
Quantitative PCR assessments of bacterial species in women with and without bacterial vaginosis. J Clin Microbiol (2010) 1.69
Severity of bacterial vaginosis and the risk of sexually transmitted infection. Am J Obstet Gynecol (2011) 1.69
Quantitative determination by real-time PCR of four vaginal Lactobacillus species, Gardnerella vaginalis and Atopobium vaginae indicates an inverse relationship between L. gasseri and L. iners. BMC Microbiol (2007) 1.66
Bacterial vaginosis and anaerobic bacteria are associated with endometritis. Clin Infect Dis (2004) 1.65
Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol (2005) 1.60
The vaginal bacterial communities of Japanese women resemble those of women in other racial groups. FEMS Immunol Med Microbiol (2009) 1.59
Bacterial vaginosis in pregnancy: distribution of bacterial species in different gram-stain categories of the vaginal flora. J Med Microbiol (1996) 1.57
The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. J Infect Dis (2006) 1.55
Comparison between Gram stain and culture for the characterization of vaginal microflora: definition of a distinct grade that resembles grade I microflora and revised categorization of grade I microflora. BMC Microbiol (2005) 1.55
Detection of bacterial vaginosis-related organisms by real-time PCR for Lactobacilli, Gardnerella vaginalis and Mycoplasma hominis. FEMS Immunol Med Microbiol (2002) 1.54
Association between Lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women. BMC Infect Dis (2007) 1.51
Evidence relating bacterial vaginosis to intraamniotic infection. Am J Obstet Gynecol (1989) 1.34
Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol (2007) 1.30
Prevalence and abundance of uncultivated Megasphaera-like bacteria in the human vaginal environment. Appl Environ Microbiol (2008) 1.29
Bacterial vaginosis and anaerobes in obstetric-gynecologic infection. Clin Infect Dis (1993) 1.28
Role of bacterial vaginosis in pelvic inflammatory disease. Clin Infect Dis (1995) 1.25
Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women. PLoS One (2012) 1.16
Interrelationships of bacterial vaginosis and cervical inflammation. Sex Transm Dis (2002) 1.07
Preliminary characterization of vaginal microbiota in healthy Chinese women using cultivation-independent methods. J Obstet Gynaecol Res (2009) 1.07
Longitudinal qPCR study of the dynamics of L. crispatus, L. iners, A. vaginae, (sialidase positive) G. vaginalis, and P. bivia in the vagina. PLoS One (2012) 1.06
A multiplex polymerase chain reaction-based diagnostic method for bacterial vaginosis. Obstet Gynecol (2002) 1.03
Gardnerella vaginalis comprises three distinct genotypes of which only two produce sialidase. Am J Obstet Gynecol (2011) 1.03
Development and validation of a semiquantitative, multitarget PCR assay for diagnosis of bacterial vaginosis. J Clin Microbiol (2012) 0.97
Self-collected vaginal swabs for the quantitative real-time polymerase chain reaction assay of Atopobium vaginae and Gardnerella vaginalis and the diagnosis of bacterial vaginosis. Eur J Clin Microbiol Infect Dis (2011) 0.88
Bacterial vaginosis: prevalence and predictive value for premature delivery and neonatal infection in women with preterm labour and intact membranes. Eur J Obstet Gynecol Reprod Biol (2003) 0.87
Microscopy of the bacterial flora on fresh vaginal smears. Infect Dis Obstet Gynecol (1999) 0.82
Pilot study to evaluate the appropriate management of patients with coexistent bacterial vaginosis and cervicitis. Infect Dis Obstet Gynecol (1995) 0.81
Comparative analysis of human gut microbiota by barcoded pyrosequencing. PLoS One (2008) 14.63
A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology (2010) 5.29
Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol (2011) 4.10
Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother (2011) 3.54
Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PLoS One (2010) 3.45
Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med (2003) 3.04
Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J (2008) 2.96
Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis (2009) 2.85
Helicobacter pylori infection and gastric atrophy: risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst (2004) 2.63
Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther (2009) 2.53
Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet (2012) 2.44
Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother (2009) 2.36
High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol (2005) 2.13
Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother (2007) 2.07
Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut (2013) 2.04
Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1. J Clin Microbiol (2008) 1.98
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res (2013) 1.96
Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard. J Clin Microbiol (2010) 1.85
SabA is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog (2006) 1.68
Peptic ulcer disease in a general adult population: the Kalixanda study: a random population-based study. Am J Epidemiol (2006) 1.64
Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol (2009) 1.64
Evaluation of six commercial nucleic acid amplification tests for detection of Neisseria gonorrhoeae and other Neisseria species. J Clin Microbiol (2011) 1.55
Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother (2009) 1.50
Comparison of culture and PCR for detection of Bordetella pertussis and Bordetella parapertussis under routine laboratory conditions. J Med Microbiol (2004) 1.47
Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe. Sex Transm Dis (2014) 1.46
One year of Neisseria gonorrhoeae isolates in Sweden: the prevalence study of antibiotic susceptibility shows relation to the geographic area of exposure. Int J STD AIDS (2002) 1.44
Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients. Eur J Gastroenterol Hepatol (2008) 1.42
Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother (2013) 1.41
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob Agents Chemother (2007) 1.40
In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea? Antimicrob Agents Chemother (2012) 1.37
Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci U S A (2008) 1.37
The European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP)--a sentinel approach in the European Union (EU)/European Economic Area (EEA). Sex Transm Infect (2013) 1.34
Molecular characterization of Neisseria gonorrhoeae identifies transmission and resistance of one ciprofloxacin-resistant strain. APMIS (2007) 1.33
Correlation between cag pathogenicity island composition and Helicobacter pylori-associated gastroduodenal disease. Infect Immun (2003) 1.32
Rapid detection of rifampin resistance in Mycobacterium tuberculosis by Pyrosequencing technology. J Clin Microbiol (2006) 1.31
Molecular epidemiology of Neisseria gonorrhoeae: sequence analysis of the porB gene confirms presence of two circulating strains. J Clin Microbiol (2002) 1.30
Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome. Mol Microbiol (2007) 1.30
Emergence, spread and characteristics of Neisseria gonorrhoeae isolates with in vitro decreased susceptibility and resistance to extended-spectrum cephalosporins in Sweden. Sex Transm Infect (2010) 1.28
Macrolide resistance in the normal microbiota after Helicobacter pylori treatment. Scand J Infect Dis (2007) 1.27
Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry (2010) 1.27
A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population. Scand J Gastroenterol (2005) 1.26
Lactobacillus gastricus sp. nov., Lactobacillus antri sp. nov., Lactobacillus kalixensis sp. nov. and Lactobacillus ultunensis sp. nov., isolated from human stomach mucosa. Int J Syst Evol Microbiol (2005) 1.26
Titration-free massively parallel pyrosequencing using trace amounts of starting material. Nucleic Acids Res (2010) 1.25
Impaired mucus-bicarbonate barrier in Helicobacter pylori-infected mice. Am J Physiol Gastrointest Liver Physiol (2006) 1.23
Molecular fingerprinting of the fecal microbiota of children raised according to different lifestyles. Appl Environ Microbiol (2007) 1.23
Concordance of Helicobacter pylori strains within families. J Clin Microbiol (2003) 1.22
Correlation of the Helicobacter pylori adherence factor BabA with duodenal ulcer disease in four European countries. FEMS Immunol Med Microbiol (2005) 1.21
The Swedish new variant of Chlamydia trachomatis: genome sequence, morphology, cell tropism and phenotypic characterization. Microbiology (2010) 1.21
Intestinal microbial profiles in extremely preterm infants with and without necrotizing enterocolitis. Acta Paediatr (2012) 1.20
Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J Antimicrob Chemother (2010) 1.20
A fast real-time polymerase chain reaction method for sensitive and specific detection of the Neisseria gonorrhoeae porA pseudogene. J Mol Diagn (2006) 1.20
Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens. Vaccine (2005) 1.19
Connector inversion probe technology: a powerful one-primer multiplex DNA amplification system for numerous scientific applications. PLoS One (2007) 1.18
DNA-level characterization of Helicobacter pylori strains from patients with overt disease and with benign infections in Bangladesh. J Clin Microbiol (2003) 1.18
An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. J Antimicrob Chemother (2010) 1.17
Free-living amoebae promote growth and survival of Helicobacter pylori. Scand J Infect Dis (2002) 1.15
Analytical evaluation of GeneXpert CT/NG, the first genetic point-of-care assay for simultaneous detection of Neisseria gonorrhoeae and Chlamydia trachomatis. J Clin Microbiol (2013) 1.15
Pooling samples: the key to sensitive, specific and cost-effective genetic diagnosis of Chlamydia trachomatis in low-resource countries. Acta Derm Venereol (2007) 1.14
Short tandem repeat sequences in the Mycoplasma genitalium genome and their use in a multilocus genotyping system. BMC Microbiol (2008) 1.14
A novel mechanism of high-level, broad-spectrum antibiotic resistance caused by a single base pair change in Neisseria gonorrhoeae. MBio (2011) 1.14
Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin. Arch Dermatol Res (2011) 1.14
Serum biomarkers provide an accurate method for diagnosis of atrophic gastritis in a general population: The Kalixanda study. Scand J Gastroenterol (2008) 1.14
Characterisation of Chlamydia trachomatis by ompA sequencing and multilocus sequence typing in a Swedish county before and after identification of the new variant. Sex Transm Infect (2009) 1.13
Helicobacter pylori adhesion to carbohydrates. Methods Enzymol (2006) 1.12
Comparison of serologic and genetic porB-based typing of Neisseria gonorrhoeae: consequences for future characterization. J Clin Microbiol (2003) 1.12
Antimicrobial resistance and molecular typing of Neisseria gonorrhoeae isolates in Kyoto and Osaka, Japan, 2010 to 2012: intensified surveillance after identification of the first strain (H041) with high-level ceftriaxone resistance. Antimicrob Agents Chemother (2013) 1.11
Persistence of resistant Staphylococcus epidermidis after single course of clarithromycin. Emerg Infect Dis (2005) 1.10
Design of a multiplex PCR for Streptococcus pneumoniae, Haemophilus influenzae, Mycoplasma pneumoniae and Chlamydophila pneumoniae to be used on sputum samples. APMIS (2005) 1.10
Detection of gyrA mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by rapid and reliable pre-programmed short DNA sequencing. Int J Antimicrob Agents (2005) 1.10
Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione. FASEB J (2012) 1.09
A comparative study of three different PCR assays for detection of Mycoplasma genitalium in urogenital specimens from men and women. J Med Microbiol (2008) 1.09
An enzymatic ruler modulates Lewis antigen glycosylation of Helicobacter pylori LPS during persistent infection. Proc Natl Acad Sci U S A (2006) 1.09
The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health. Sex Transm Infect (2012) 1.06
Molecular analyses of TEM genes and their corresponding penicillinase-producing Neisseria gonorrhoeae isolates in Bangkok, Thailand. Antimicrob Agents Chemother (2011) 1.06
Uptake and replication of Salmonella enterica in Acanthamoeba rhysodes. Appl Environ Microbiol (2004) 1.06
Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease. Vaccine (2009) 1.05
Genome sequencing reveals a phage in Helicobacter pylori. MBio (2011) 1.05
Comparative analysis of the complete cag pathogenicity island sequence in four Helicobacter pylori isolates. Gene (2004) 1.04
Antimicrobial susceptibility of Helicobacter pylori strains isolated in Bangladesh. J Clin Microbiol (2004) 1.03
Current and future treatment options for gonorrhoea. Sex Transm Infect (2013) 1.03
Genetic variation in the complete MgPa operon and its repetitive chromosomal elements in clinical strains of Mycoplasma genitalium. PLoS One (2010) 1.03
Coexistence of urogenital schistosomiasis and sexually transmitted infection in women and men living in an area where Schistosoma haematobium is endemic. Clin Infect Dis (2008) 1.02
Lipopolysaccharide diversity evolving in Helicobacter pylori communities through genetic modifications in fucosyltransferases. PLoS One (2008) 1.02
Pulsed-field gel electrophoresis as an epidemiologic tool for Neisseria gonorrhoeae: identification of clusters within serovars. Sex Transm Dis (2002) 1.02
Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041. Antimicrob Agents Chemother (2013) 1.01
Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins. Antimicrob Agents Chemother (2012) 1.01
Bacterial vaginosis--a laboratory and clinical diagnostics enigma. APMIS (2005) 1.01
Pyrosequencing Bacillus anthracis. Emerg Infect Dis (2005) 0.99
Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse model. Pathog Dis (2013) 0.99
Bacteria with increased mutation frequency and antibiotic resistance are enriched in the commensal flora of patients with high antibiotic usage. J Antimicrob Chemother (2003) 0.99
Genotyping of Chlamydia trachomatis would improve contact tracing. Sex Transm Dis (2003) 0.99
Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century. Microbiol Spectr (2016) 0.98
Total variation in the penA gene of Neisseria meningitidis: correlation between susceptibility to beta-lactam antibiotics and penA gene heterogeneity. Antimicrob Agents Chemother (2006) 0.98